Admetsys: An artificial pancreas for hospital settings
Boston-based startup Admetsys has developed what it calls a first-of-its kind artificial pancreas specifically designed for hospital and surgical settings. The company said the device will eliminate the need for nurses to hand check glucose levels for patients at diabetic risk during their hospital stays, and could free up as much as 20% of a nurses time on shift.
Though still in its early stages, the company has conducted 3 clinical trials of the device and has racked up victories at various global innovation contests including a competition sponsored by the Massachusetts Medical Device Development Center out of its University of Massachusetts Lowell campus.
The company’s artificial pancreas system is specifically designed to improve hospital care for patients at diabetic risk by controlling blood glucose and protecting the patient from hypoglycemia by infusing counterbalancing insulin and dextrose medications. The system monitors blood glucose levels in real time, the company said, and creates a computational model of the patient’s metabolism to deliver a personally optimized treatment.
Last January, Admetsys inked a collaborative deal with Hospira to use its 50% dextrose for injection and its Ansyr II polypropylene syringe system as part of its artificial pancreas platform.